A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

This study has been suspended.

Study NCT00540332. Last updated on November 6, 2008. Information provided by Amgen

Please refer to this study by its ClinicalTrials.gov identifier: NCT00540332

Locations


Czech Republic
	Research Site
	Brno, Czech Republic
	Research Site
	Praha 8_, Czech Republic

France
	Research Site
	Angers, France

Germany
	Research Site
	Freiburg, Germany
	Research Site
	Homburg, Germany
	Research Site
	Leipzig, Germany

Sponsors and Collaborators

Amgen

Investigators


Study Director:	MD	Amgen